Eltrombopag in Good’s Syndrome [PDF]
Case Reports in Hematology, 2014 Good’s syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias.
Håvard Anton Kristiansen +3 more
doaj +3 more sources
Insights from a Case of Good’s Syndrome (Immunodeficiency with Thymoma) [PDF]
Biomedicines, 2023 Immunodeficiency with thymoma was described by R.A. Good in 1954 and is also named after him. The syndrome is characterized by hypogammaglobulinemia associated with thymoma and recurrent infections, bacterial but also viral, fungal and parasitic ...
Roberto Paganelli +6 more
doaj +3 more sources
Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good’s syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report [PDF]
BMC Infectious Diseases, 2020 Background Good’s syndrome (GS) is characterized by immunodeficiency, and can lead to severe infection, which is the most significant complication.
Waki Imoto +19 more
doaj +3 more sources
COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study [PDF]
BMC CancerIntroduction Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good’s syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mortality due to infectious diseases.
Erica Pietroluongo +25 more
doaj +2 more sources
A Case of Severe COVID-19 in a Patient with Good's Syndrome
European Journal of Case Reports in Internal Medicine, 2021 Good’s syndrome is a rare adult-onset combined immunodeficiency. The association of hypogammaglobulinaemia with a history of recurrent infectious or autoimmune manifestations in a middle-aged patient with evidence of a mediastinal mass should lead to the
Maria Duarte +4 more
doaj +1 more source
Good’s syndrome with increasing γδ T-lymphocyte subpopulation: A case report [PDF]
Vojnosanitetski Pregled, 2015 Introduction. Good’s syndrome is a rare cause of adultonset immunodeficiency associated with thymoma. Good’s syndrome should be considered in patients older than 40 years with the history of frequent infections.
Tadić Dragana +3 more
doaj +1 more source
Good's Syndrome with Pneumocystis Jiroveci Lymphadenitis and Pure Red Cell Aplasia [PDF]
Journal of Microbiology and Infectious Diseases, 2016 Pneumocystis jiroveci lymphadenitis is a rare manifestation of extrapulmonary pneumocystosis. A case of recurrent infection with lymphadenitis caused by Pneumocystis jiroveci in a middle-aged patient is described.
Jintana - Srisompong, Torpong - Thongngarm, Popchai - Ngamskulrungroj, Ruchira - Ruangchira-urai, Adhiratha - Boonyasiri
doaj +1 more source
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency
Clinical Immunology Communications, 2021 Antibody deficiencies constitute the majority of primary immunodeficiencies in adults. These patients have a well-established increased risk of bacterial infections but there is a lack of knowledge regarding the relative risks upon contracting COVID-19 ...
Hannes Lindahl +2 more
doaj +1 more source
Cerebral toxoplasmosis in a patient with myasthenia gravis and thymoma with immunodeficiency/Good’s syndrome: a case report [PDF]
, 2016 Background Patients with thymoma with immunodeficiency (TWI)/Good’s syndrome characteristically have evidence of combined immunodeficiency including low or absent B-cells, hypogammaglobulinemia and defects in T-cell mediated immunity.
Chan, R +4 more
core +6 more sources
Frontiers in Medicine, 2021 Background: Thymoma-associated haematological diseases (HDs), such as pure red cell aplasia (PRCA) and Good's syndrome, are extremely rare, and due to the paucity of large-scale studies, the characteristics, remission after thymectomy, and long-term ...
Chih-Chieh Yen +9 more
doaj +1 more source